Junbiao Hang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
- Tracheal and airway disorders
Papers in
-
- Lung Cancer Diagnosis and Treatment 7
- Lung Cancer Treatments and Mutations 3
- Ferroptosis and cancer prognosis 2
- Surgery 14
- Esophageal Cancer Research and Treatment 6
- Esophageal and GI Pathology 4
- Salivary Gland Tumors Diagnosis and Treatment 2
- Co-authors
- Jiaming Che (9 shared papers)Hecheng Li (15 shared papers)Jie Xiang (4 shared papers)Jie Xiang (7 shared papers)Dingpei Han (9 shared papers)Zhihong Xu (4 shared papers)Jiaan Hu (4 shared papers)Runsen Jin (4 shared papers)
- Journals
- Annals of Translational Medicine (3 papers)BioMed Research International (2 papers)International Journal of Surgery (1 paper)Cancer Biomarkers (1 paper)The Annals of Thoracic Surgery (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Junbiao Hang
27 papers receiving 347 citations
Peers
Comparison fields: 5 of 50
- Cancer Research 80
- Pulmonary and Respiratory Medicine 167
- Surgery 138
- Oncology 60
- Molecular Biology 127
Countries citing papers authored by Junbiao Hang
This map shows the geographic impact of Junbiao Hang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbiao Hang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbiao Hang more than expected).
Fields of papers citing papers by Junbiao Hang
This network shows the impact of papers produced by Junbiao Hang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbiao Hang. The network helps show where Junbiao Hang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junbiao Hang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 54 | |
| 2 | MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7. | 2015 | 47 |
| 3 | 2018 | 25 | |
| 4 | 2013 | 24 | |
| 5 | 2021 | 20 | |
| 6 | RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib. | 2013 | 19 |
| 7 | 2018 | 19 | |
| 8 | 2023 | 18 | |
| 9 | 2018 | 18 | |
| 10 | 2015 | 15 | |
| 11 | 2020 | 15 | |
| 12 | Gefitinib, an EGFR tyrosine kinase inhibitor, activates autophagy through AMPK in human lung cancer cells. | 2014 | 14 |
| 13 | 2017 | 13 | |
| 14 | 2021 | 10 | |
| 15 | 2016 | 7 | |
| 16 | 2017 | 6 | |
| 17 | 2017 | 5 | |
| 18 | 2019 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2016 | 4 |
About Junbiao Hang
Junbiao Hang is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Epidemiology, having authored 27 papers that have together received 353 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (7 papers), Esophageal Cancer Research and Treatment (6 papers), Esophageal and GI Pathology (4 papers), Lung Cancer Treatments and Mutations (3 papers), Autophagy in Disease and Therapy (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers) and Salivary Gland Tumors Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (80 citations), Pulmonary and Respiratory Medicine (167 citations), Surgery (138 citations), Oncology (60 citations) and Molecular Biology (127 citations). Junbiao Hang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Jiaming Che, Hecheng Li, Jie Xiang, Jie Xiang, Dingpei Han, Zhihong Xu, Jiaan Hu, Runsen Jin, Beili Gao and Yu Han. Their work appears in journals such as Annals of Translational Medicine, BioMed Research International, International Journal of Surgery, Cancer Biomarkers and The Annals of Thoracic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.